The estimated Net Worth of Scott Stromatt is at least 250 千$ dollars as of 31 August 2007. Scott Stromatt owns over 625 units of CTI BioPharma Corp stock worth over 51,131$ and over the last 19 years Scott sold CTIC stock worth over 198,469$.
Scott has made over 7 trades of the CTI BioPharma Corp stock since 2005, according to the Form 4 filled with the SEC. Most recently Scott sold 625 units of CTIC stock worth 2,419$ on 31 August 2007.
The largest trade Scott's ever made was selling 27,500 units of CTI BioPharma Corp stock on 29 August 2005 worth over 69,025$. On average, Scott trades about 7,548 units every 56 days since 2005. As of 31 August 2007 Scott still owns at least 5,625 units of CTI BioPharma Corp stock.
You can see the complete history of Scott Stromatt stock trades at the bottom of the page.
Scott's mailing address filed with the SEC is 501 ELLIOTT AVE. W., SUITE 400, SEATTLE, WA, 98119.
Over the last 21 years, insiders at CTI BioPharma Corp have traded over 80,110,449$ worth of CTI BioPharma Corp stock and bought 9,566,060 units worth 25,487,533$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog...、Advisors Llc Orbi Med Capit.... On average, CTI BioPharma Corp executives and independent directors trade stock every 26 days with the average trade being worth of 1,223,687$. The most recent stock trade was executed by Adam R Craig on 24 January 2023, trading 85,317 units of CTIC stock currently worth 71,666$.
cti was founded on the belief that a coalition between unique scientific technology and its strong desire to “do right” by the patient could help us achieve our mission to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. we strive to do business better than other biopharmaceutical companies. better means a more collaborative, well-trained team environment willing to institute novel approaches to scientific discovery and business opportunities. a willingness to push the limits to achieve challenging goals is the essential attribute that sets cti employees apart.
CTI BioPharma Corp executives and other stock owners filed with the SEC include: